External traditional Chinese medicine compound temperature-sensitive slow-release hydrogel as well as preparation method and application thereof

By combining hyaluronic acid and chitosan quaternary ammonium microgel with Chinese medicine compound and temperature-sensitive material F127/F68, a Chinese medicine compound that can be used as a solution at room temperature and becomes a gel after contacting the skin is prepared. The sustained-release hydrogel solves the problem of major side effects of existing glucocorticoid drugs and achieves efficient and convenient treatment of allergic contact dermatitis.

CN118986848APending Publication Date: 2024-11-22GUANGZHOU SAI ANSI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410957800.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-17
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

The existing glucocorticoid drugs for the treatment of allergic contact dermatitis have serious side effects, resulting in patients being cautious in using it and lacking efficient and convenient topical preparations for traditional Chinese medicine.

Method used

A combination of hyaluronic acid and chitosan quaternary ammonium microgels combined with Chinese medicine compound water extract and temperature-sensitive materials F127 and F68 was prepared to prepare a topical Chinese medicine compound temperature-sensitive sustained release hydrogel. The hydrogel is at room temperature It is a solution that quickly turns into a gel after contacting the skin, with temperature-sensitive and sustained release effects, making it easy to store and use.

Benefits of technology

The hydrogel achieves phase change at the average temperature of the human skin surface, quickly covers and releases Chinese medicine ingredients, significantly reducing the itchy symptoms of allergic contact dermatitis, and is better than traditional drugs and has no obvious side effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118986848A_ABST
    Figure CN118986848A_ABST
Patent Text Reader

Abstract

The invention discloses external traditional Chinese medicine compound temperature-sensitive slow-release hydrogel as well as a preparation method and application thereof. The preparation method comprises the following steps: uniformly mixing a hyaluronic acid aqueous solution and a chitosan quaternary ammonium salt aqueous solution, centrifuging to take supernate, and freeze-drying to obtain a hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried substance; and uniformly mixing the hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried substance, the traditional Chinese medicine compound water extract freeze-dried powder, a temperature-sensitive material and water to obtain the external traditional Chinese medicine compound temperature-sensitive slow-release hydrogel. The traditional Chinese medicine compound preparation can be quickly converted into a gel state from a solution state when being in contact with the skin of a patient, the traditional Chinese medicine compound preparation covers an affected part and is not easy to fall off, and the sustained-release hydrogel has the unique advantages of prolonging the administration time, reducing the administration frequency, reducing adverse reactions and being easily accepted by the patient, can be used for relieving allergic contact dermatitis non-histamine-dependent itching, and has a good application prospect. Wide clinical application prospects are realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of medical hydrogels, and specifically relates to a traditional Chinese medicine compound thermosensitive sustained-release hydrogel for external use, and a preparation method and application thereof. Background Art

[0002] Allergic contact dermatitis (ACD) is a type IV (delayed) allergic reaction, which is an inflammatory reaction that occurs at the contact site when the skin and mucous membranes come into contact with the same antigen again. It causes severe itching of the skin, thus affecting the patient's mood, work and quality of life. In severe cases, it may even cause depression or suicidal tendencies.

[0003] At present, there are many methods for treating ACD clinically, such as topical glucocorticoids, emollients, phototherapy, calcium neuron inhibitors, immunosuppressants, etc., among which glucocorticoids are still the main choice for clinicians. However, due to the chronic nature of the disease, the possible side effects of glucocorticoids make doctors and patients extremely cautious in their use. For example, long-term use of steroids including dexamethasone can lead to skin deterioration, facial edema, psoriasis, furunculosis, dryness and bleeding. For these reasons, ACD patients are hesitant to take such drugs because they have serious side effects. It is an urgent clinical need to study effective and easy-to-use Chinese medicine topical preparations for the treatment of allergic contact dermatitis. Summary of the invention

[0004] The primary purpose of the present invention is to overcome the deficiencies in the prior art and provide a method for preparing a thermosensitive sustained-release hydrogel of a traditional Chinese medicine compound for external use.

[0005] Another object of the present invention is to provide a compound thermosensitive sustained-release hydrogel of traditional Chinese medicine for external use obtained by the above preparation method. The hydrogel is a compound thermosensitive sustained-release hydrogel of traditional Chinese medicine for external use for treating non-histamine-dependent pruritus, which is in a solution state at room temperature and is convenient for spraying on the affected area. When it contacts the skin, it can quickly change from a solution state to a gel state to cover the affected area, achieving the purpose of thermosensitivity, sustained release, convenient storage and use.

[0006] Another object of the present invention is to provide an application of the above-mentioned external Chinese medicine compound temperature-sensitive sustained-release hydrogel.

[0007] The purpose of the present invention is achieved by the following technical scheme: A method for preparing a thermosensitive sustained-release hydrogel of a traditional Chinese medicine compound for external use, comprising the following steps:

[0008] (1) mixing a hyaluronic acid (HA) aqueous solution and a chitosan quaternary ammonium salt (HTCC) aqueous solution uniformly, centrifuging to obtain a supernatant, and freeze-drying to obtain a hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried product;

[0009] (2) The hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried product, the Chinese medicine compound water extract freeze-dried powder, the thermosensitive material and water are mixed evenly to obtain the external Chinese medicine compound thermosensitive sustained-release hydrogel.

[0010] In the hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried product described in step (1), hyaluronic acid and chitosan quaternary ammonium salt are mixed in a mass ratio of 1:1.

[0011] The concentration of the hyaluronic acid aqueous solution in step (1) is preferably 0.01 to 2 mg / mL; more preferably 1.0 mg / mL.

[0012] The concentration of the chitosan quaternary ammonium salt aqueous solution described in step (1) is preferably 0.01-2 mg / mL; more preferably 1.0 mg / mL.

[0013] The mixing method described in step (1) is preferably to inject the chitosan quaternary ammonium salt aqueous solution into the hyaluronic acid aqueous solution under stirring, and continue stirring after the injection.

[0014] The injection rate is preferably 0.02-0.2 mL / s; preferably 0.05 mL / s.

[0015] The stirring speed is preferably 600-1200 rpm, and more preferably 900 rpm.

[0016] The stirring time is preferably 0.5 to 8 hours, more preferably 3 hours.

[0017] The centrifugation conditions in step (1) are preferably centrifuged at 6000-8000 rpm for 5-15 min; more preferably centrifuged at 7000 rpm for 10 min.

[0018] The Chinese medicine compound freeze-dried powder described in step (2) is preferably prepared by the following steps:

[0019] 1) Soaking the Chinese medicinal compound in water, decocting, centrifuging the obtained medicinal solution, and taking the supernatant;

[0020] 2) Concentrating the supernatant obtained in step 1) and freeze-drying to obtain a freeze-dried powder of the Chinese medicine compound.

[0021] The amount of water used in step 1) is preferably an amount that can immerse the Chinese medicinal compound.

[0022] The soaking time in step 1) is 0.5 h to 2 h, preferably 1 h.

[0023] The number of decoctions in step 1) is preferably 1 to 3 times; after each decoction, the medicinal liquid and the medicinal residue are separated, and water is added to repeat the decoction.

[0024] The specific operation of decocting in step 1) is preferably as follows: decocting over low heat after boiling.

[0025] The temperature of the low fire is 50-80°C, preferably 70°C.

[0026] The low-heat decocting time is 10 to 60 minutes, preferably 20 minutes.

[0027] The centrifugation condition in step 1) is preferably centrifuged at 6000-8000 rpm for 5-15 min; more preferably centrifuged at 7000 rpm for 10 min.

[0028] The concentration method in step 2) is preferably rotary evaporation.

[0029] The rotary evaporation conditions are preferably 50-80°C, 70-120rpm; more preferably 60°C, 100rpm.

[0030] The degree of concentration in step 2) is preferably concentrated to 0.01 g / mL to 1.0 g of raw medicinal material / mL; more preferably concentrated to 0.2 g of raw medicinal material / mL.

[0031] The composition of the Chinese herbal compound described in step (2) is preferably as follows: Sophora flavescens, Cnidium monnieri, Kochia scoparia, Dictamni, Gallbladder wood, Cnidium monnieri and Liquidambar formosana leaves are mixed in a mass ratio of 1:1:1:1:1:1:1:1.

[0032] The temperature-sensitive material described in step (2) is preferably a compound of F127 and F68; more preferably, it is a compound of F127 and F68 in a mass ratio of 42:1.

[0033] The mixing conditions in step (2) are preferably a temperature of 2 to 8° C. and a stirring speed of 500 to 1200 rpm; more preferably a temperature of 5° C. and a stirring speed of 900 rpm.

[0034] The components in the external Chinese medicine compound thermosensitive sustained-release hydrogel described in step (2) are calculated by mass percentage as follows: hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried material 0.1-1.5%, Chinese medicine compound water extract freeze-dried powder 0.1-0.3%, thermosensitive material 18.1-26%, water balance; preferably as follows: hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried material 1.0%, Chinese medicine compound water extract freeze-dried powder 0.2%, thermosensitive material 21.5%, water balance.

[0035] The water described in step (2) is preferably ultrapure water.

[0036] A traditional Chinese medicine compound thermosensitive sustained-release hydrogel for external use is prepared by the method.

[0037] Application of topical Chinese herbal compound thermosensitive sustained-release hydrogel in the preparation of preparations for the treatment of non-histamine-dependent pruritus and allergic contact dermatitis.

[0038] Compared with the prior art, the present invention has the following advantages and effects:

[0039] In the process of preparing the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound, it is found that single F127 is difficult to adjust the phase transition temperature of the system containing the water extract of the traditional Chinese medicine compound and HA-HTCC microspheres. The present invention adds the traditional Chinese medicine compound and HA-HTCC microspheres to Pluronic F127, and uses F68 to fine-tune the phase transition temperature of the entire composite system. F68 also has temperature sensitivity. Contrary to the characteristics of F127, the thermosensitive temperature of the system can increase with the increase of F68 concentration, overcoming the limitation of the thermosensitive temperature of the system controlled by single F127, and can adjust the temperature to the average temperature of the human skin surface (target temperature: 32°C), so that the prepared thermosensitive sustained-release hydrogel of traditional Chinese medicine compound is in a solution state at room temperature, which is convenient for spraying on the affected area. When it contacts the skin, it can quickly change from a solution state to a gel state to cover the affected area, and has temperature sensitivity, is convenient for storage and easy to use. The three-dimensional network structure formed by the thermosensitive materials F127 and F68 encapsulates the Chinese herbal compound and HA-HTCC microspheres, wherein part of the Chinese herbal compound is encapsulated in the HA-HTCC microspheres. After contacting the skin, the components of the Chinese herbal compound that are not encapsulated by the microspheres are released first, and the components in the microspheres are released from the microspheres as the concentration gradient changes. The Chinese herbal compound achieves a sustained release effect under the joint action of the HA-HTCC microspheres and the hydrogel network. BRIEF DESCRIPTION OF THE DRAWINGS

[0040] Figure 1 This is a transmission electron microscopy characterization image of hyaluronic acid (HA) / chitosan quaternary ammonium salt (HTCC) microgel.

[0041] Figure 2 This is the appearance picture of the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound.

[0042] Figure 3 : are rheological properties diagrams of thermosensitive sustained-release hydrogels of traditional Chinese medicine; wherein, (A) is a rheological properties diagram of thermosensitive sustained-release hydrogels of traditional Chinese medicine under different strains, (B) is a rheological properties diagram of thermosensitive sustained-release hydrogels of traditional Chinese medicine at different temperatures, (C) is a rheological properties diagram of thermosensitive sustained-release hydrogels of traditional Chinese medicine at different frequencies, and (D) is a temperature-viscosity curve diagram of thermosensitive sustained-release hydrogels of traditional Chinese medicine.

[0043] Figure 4 The graphs show the test results of phase transition temperature (left) and gel time (right) at various F127 concentrations.

[0044] Figure 5This is a graph showing the effect of Chinese medicine compound microspheres on the F127 system; the left graph is the phase transition temperature, and the right graph is the gel time.

[0045] Figure 6 This is a graph showing the effects of Chinese medicine compound microspheres and F68 on the F127 system; the left graph is the phase transition temperature, and the right graph is the gel time.

[0046] Figure 7 This is a graph showing the effect of a thermosensitive sustained-release hydrogel of a traditional Chinese medicine compound on the cheek scratching behavior of mice in the ACD cheek model induced by squaric acid dibutyl ester (SADBE). DETAILED DESCRIPTION

[0047] The present invention is further described in detail below in conjunction with the examples and drawings, but the embodiments of the present invention are not limited thereto. The reagents or instruments used without indicating the manufacturer are all conventional products that can be purchased commercially.

[0048] Example 1

[0049] (1) Preparation of freeze-dried powder of Chinese herbal compound water extract: Chinese herbal compound medicinal materials (10 g of Sophora flavescens, 10 g of Cnidium monnieri, 10 g of Kochia scoparia, 10 g of Dictamni cortex, 10 g of Gallbladder wood, 10 g of Millettia repens, and 10 g of Liquidambar formosana leaves) were weighed and 500 mL of water was added to cover the medicinal materials, and the mixture was soaked for 1 h. After boiling, the mixture was decocted at 70° C. for 20 min on low heat, filtered, and the medicinal liquid was poured out. 4 / 5 of the first amount of water was added to the decoction container, and the mixture was decocted again. After boiling, the mixture was decocted at low heat for 20 min on low heat, filtered, and the medicinal liquids after the two decoctions and filtrations were combined, centrifuged at 7000 rpm for 10 min, and the supernatant was collected. The supernatant was concentrated to 0.2 g / mL (calculated based on the amount of crude drugs) by rotary evaporation at 60° C. and 100 rpm to obtain a Chinese herbal compound water extract, which was lyophilized to obtain a freeze-dried powder of the Chinese herbal compound water extract.

[0050] (2) Preparation of hyaluronic acid (HA) / chitosan quaternary ammonium salt (HTCC) microgel lyophilized product: prepare a hyaluronic acid (HA) aqueous solution with a concentration of 1.0 mg / mL, prepare a chitosan quaternary ammonium salt aqueous solution with a concentration of 1.0 mg / mL, slowly and uniformly inject 50 mL of the chitosan quaternary ammonium salt aqueous solution into 50 mL of the hyaluronic acid aqueous solution at a rate of 0.05 mL / s, stir at 900 rpm for 3 h, centrifuge at 7000 rpm for 10 min, take the supernatant, and freeze-dry to obtain hyaluronic acid (HA) / chitosan quaternary ammonium salt (HTCC) microgel lyophilized product. The morphology of hyaluronic acid (HA) / chitosan quaternary ammonium salt (HTCC) microgel was observed using a transmission electron microscope. The hyaluronic acid (HA) / chitosan quaternary ammonium salt (HTCC) microgel was round in appearance and uniform in size (such as Figure 1 shown).

[0051] (3) Preparation of thermosensitive sustained-release hydrogel of traditional Chinese medicine compound: add the prescribed amount of lyophilized powder of traditional Chinese medicine compound water extract, lyophilized product of hyaluronic acid (HA) / chitosan quaternary ammonium salt (HTCC) microgel, F127, F68 and ultrapure water, stir and mix thoroughly at 4°C and 900 rpm to obtain the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound; wherein the weight percentage of each substance is: 0.2% of lyophilized powder of traditional Chinese medicine compound water extract, 1.0% of lyophilized product of hyaluronic acid (HA) / chitosan quaternary ammonium salt (HTCC) microgel, 21% of F127, 0.5% of F68 and 77.3% of ultrapure water.

[0052] The appearance of the prepared thermosensitive sustained-release hydrogel of traditional Chinese medicine compound was evaluated, and its rheological properties were tested using a rotational rheometer. The thermosensitive sustained-release hydrogel of traditional Chinese medicine compound was in a solution state at 25°C, and it was transformed from a solution state to a gel state at 32°C. The color was orange-yellow and there was no precipitation (such as Figure 2 The rheological test results are shown in Figure 3 As shown: Figure 3 (A) is the rheological performance diagram of the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound under different strains. The storage modulus and loss modulus of the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound can be kept stable in the strain range of 0.001% to 1%, indicating that it has a certain stability. Figure 3 (B) is the rheological performance diagram of the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound at different temperatures. After 32°C, both the storage modulus and the loss modulus tend to be stable and the storage modulus is greater than the loss modulus, indicating that the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound can stably maintain the gel state at temperatures of 32°C and above; Figure 3 (C) is the rheological performance diagram of the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound at different frequencies. The storage modulus of the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound can be kept stable within the frequency range of 0.1 to 100 rad / s, indicating that it has a certain stability. Figure 3 (D) in the figure is the temperature-viscosity curve of the thermosensitive sustained-release hydrogel of traditional Chinese medicine compound. When the temperature is greater than 32°C, the viscosity growth rate tends to be slow, indicating that it gradually changes from a solution state to a gel state.

[0053] Comparative Example 1

[0054] Preparation of F127 solution: Take a sample bottle, accurately weigh F127, prepare 18% (w / w), 19% (w / w), 20% (w / w), 21% (w / w), 22% (w / w), 23% (w / w), and 24% (w / w) F127 aqueous solutions, 10 mL for each concentration, and prepare using the "cold dissolution method".

[0055] Determination of phase transition temperature: Take the sample out of a refrigerator at 4°C. Then, transfer 10 mL of the sample to a sample bottle and place it at room temperature (25°C) for 10 minutes. Then, transfer the sample to a water bath and gradually heat it from 25°C to 50°C at a rate of 1°C per minute. During the heating process, the sample bottle is tilted at a 45° angle for every 1°C increase. Observe the flow of the solution and use a thermometer to continuously measure the water temperature. When the solution solidifies into a gel and cannot be poured within 10 seconds of inverting the sample bottle, the phase transition temperature is the water bath temperature. Repeat the experiment 3 times.

[0056] Determination of gel time: Take the sample out of the 4℃ refrigerator, take 10mL of the sample into a sample bottle, adapt it to room temperature (25℃) for 10 minutes, put it into a 37℃ constant temperature water bath, take out the sample bottle every 30 seconds, tilt it at 45℃ to observe the flow of the solution in the bottle, when the solution becomes gel and does not flow within 10 seconds when the sample bottle is inverted, it is considered to have completely turned into a gel state. The time required from the sample bottle being placed in the water bath to the solution in the sample bottle completely turning into a gel state is recorded as the gel time. Repeat the experiment 3 times.

[0057] The results are as follows Figure 4 As shown, from Figure 4 It can be seen that 18% to 24% (w / w) F127 solutions have good fluidity and are clear and transparent at 4°C. At 37°C, all groups of F127 solutions can undergo phase transition to form gels. With the increase of F127 concentration, the phase transition temperature decreases and the gel time shortens.

[0058] Comparative Example 2

[0059] 1. Effect of microspheres containing Chinese medicine compound on phase transition temperature and gel time of F127

[0060] Samples containing three different concentrations of F127 were prepared with ultrapure water according to the following ratios and stirred at 4°C and 900 rpm for 24 hours to fully dissolve. The determination of phase transition temperature and gel time was as described above.

[0061] (1) 19% (w / w) F127, 0.2% (w / w) lyophilized powder of Chinese medicine compound water extract, and 1.0% (w / w) lyophilized powder of HA-HTCC microspheres;

[0062] (2) 20% (w / w) F127, 0.2% (w / w) lyophilized powder of Chinese medicine compound water extract, and 1.0% (w / w) lyophilized powder of HA-HTCC microspheres;

[0063] (3) 21% (w / w) F127, 0.2% (w / w) lyophilized powder of Chinese medicine compound water extract, and 1.0% (w / w) lyophilized powder of HA-HTCC microspheres.

[0064] The results are as follows Figure 5 As shown, the average phase transition temperatures of the three samples were measured to be 37.4° C., 34.7° C., and 31.3° C., respectively. Among the three concentrations, 21% (w / w) F127 was closest to the target temperature.

[0065] 2. Effects of Chinese medicine compound microspheres and F68 on the phase transition temperature and gel time of F127

[0066] 21% (w / w) was selected as the F127 concentration used in the next step of development. F68 was added to adjust the phase transition temperature of the system. Samples containing three different concentrations of F68 were prepared with ultrapure water according to the following ratios and stirred at 4°C and 900 rpm for 24 hours to fully dissolve them. The determination of phase transition temperature and gel time was as described above.

[0067] (1) 0.5% (w / w) F68, 21% (w / w) F127, 0.2% (w / w) lyophilized powder of Chinese medicine compound water extract, and 1.0% (w / w) lyophilized powder of HA-HTCC microspheres;

[0068] (2) 1.0% (w / w) F68, 21% (w / w) F127, 0.2% (w / w) lyophilized powder of Chinese medicine compound water extract, and 1.0% (w / w) lyophilized powder of HA-HTCC microspheres;

[0069] (3) 1.5% (w / w) F68, 21% (w / w) F127, 0.2% (w / w) lyophilized powder of Chinese herbal medicine compound water extract, and 1.0% (w / w) lyophilized powder of HA-HTCC microspheres.

[0070] The results are as follows Figure 6 As shown, from Figure 6 It can be seen that after adding HA-HTCC microspheres containing traditional Chinese medicine compound, the phase transition temperature of the system increases and the gel time increases.

[0071] Example 2 Effect of the Chinese herbal compound thermosensitive sustained-release hydrogel on the treatment of non-histamine-dependent pruritus in mice with allergic contact dermatitis induced by squaric acid dibutyl ester (SADBE).

[0072] 1. Experimental methods

[0073] (1) Establishment and administration of SADBE-induced ACD cheek model in mice

[0074] A total of 105 SPF male C57BL / 6 mice (6 weeks old, weighing 20-25 g, purchased from Zhuhai Baishitong Biotechnology Co., Ltd.), 15 mice in each group, were divided into control group, model group, blank gel (containing microspheres) group, Chinese medicine compound ZYF administration group, Chinese medicine compound ZYF gel group (without microspheres), Chinese medicine compound ZYF thermosensitive sustained-release hydrogel group, and compound dexamethasone acetate ointment positive drug group.

[0075] Two days before modeling, i.e., Day-1, mice in each group were briefly anesthetized with 1% sodium pentobarbital, and their abdomens (approximately 2×2 cm) were extruded with an electric spatula. 2 ) The hair of the mice in the control group was shaved off. During the sensitization period (Day 1 to Day 3), 25 μL of acetone was evenly applied to the shaved area of ​​the abdomen for 3 consecutive days, while 25 μL of 1% SADBE solution was applied to the same area of ​​the mice in the other groups. On the sixth day of the experiment (Day 6), after a brief anesthesia with 1% sodium pentobarbital, the left and right cheeks of the mice (area of ​​about 1×1 cm) were smeared. 2 ) The hair was shaved off and the thickness of the skin fold on the right cheek was measured with a vernier caliper. On the 8th to 10th day of the experiment (i.e., the stimulation period, Day 8 to Day 10), 25 μL of acetone solution was evenly applied to the shaved area on the right cheek of the control group, and 25 μL of 1% SADBE solution was applied to the same area of ​​the mice in other groups. At this point, the model was successfully established. 6 hours after the 1% SADBE solution was applied to the cheek during the stimulation period, the drug can be administered.

[0076] On the 8th to 10th day of the experiment (i.e., the stimulation period, Day 8 to Day 10), the control group, model group (Model), blank gel group (containing microspheres) (Blank 60 μL of normal saline, 60 μL of normal saline, 60 μL of blank gel (containing microspheres), 60 μL of Chinese herbal compound ZYF water extract (0.2 g / mL), 60 μL of Chinese herbal compound ZYF gel (0.2 g / mL), 60 μL of Chinese herbal compound ZYF thermosensitive sustained-release hydrogel (0.2 g / mL), and 200 mg of compound dexamethasone acetate ointment (30 g: 22.5 mg, containing 1‰ menthol and camphor) were applied to the abdomen of mice in each group, respectively. The shaved area on the right cheek was smeared with 30 μL of normal saline, 30 μL of normal saline, 30 μL of blank gel (containing microspheres), 30 μL of Chinese medicine compound ZYF water extract (0.2 g / mL), 30 μL of Chinese medicine compound ZYF gel (0.2 g / mL), 30 μL of Chinese medicine compound ZYF thermosensitive sustained-release hydrogel (0.2 g / mL), and 100 mg of compound dexamethasone acetate ointment (30 g: 22.5 mg) according to the groups, once a day for 3 consecutive days.

[0077] On the 9th and 10th days, the mice were placed in a mouse behavior box to adapt for 1.5 h.

[0078] On day 11, the mice were placed in a behavioral mouse box for adaptation. After 30 minutes, a 1-hour video recording was performed to record the spontaneous behavior of the mice.

[0079] Among them, the blank gel group (containing microspheres) contained 0.5% (w / w) F68, 21% (w / w) F127 and 1.0% (w / w) HA-HTCC microsphere lyophilized products; F68, F127 and HA-HTCC microsphere lyophilized products were prepared with ultrapure water and stirred at 4°C and 900 rpm for 24 hours to fully dissolve them.

[0080] The Chinese herbal compound ZYF in the Chinese herbal compound ZYF administration group is a 0.2 g / mL (calculated based on the raw drug amount) Chinese herbal compound water extract obtained according to step (1) of Example 1.

[0081] The preparation of the Chinese medicine compound ZYF gel group (without microspheres) is basically the same as that of Example 1, except that HA-HTCC microspheres are not added.

[0082] The Chinese medicine compound ZYF thermosensitive sustained-release hydrogel group is a group in which the Chinese medicine compound ZYF thermosensitive sustained-release hydrogel is prepared using Example 1.

[0083] (2) Analysis of mouse scratching behavior

[0084] Scratching behavior refers to the action of mice scratching their cheeks with their hind legs. Usually, when the mouse lifts its hind legs and puts them back to the ground or mouth, it is recorded as an episode of scratching behavior. A single scratching action may include one or more repeated scratching of the cheeks by the hind legs, so sometimes such behavior may last for about 0.5 to 2 seconds or longer. When mice scratch their cheeks, their hind paws usually leave a small amount of skin or hair fragments. Therefore, after scratching, mice usually put their hind paws in their mouths to clean them. In order to eliminate other possible interference factors, the video was played in slow motion multiple times, and the data was double-blinded by personnel who were unaware of the experimental groups and objectives.

[0085] (3) Statistical analysis

[0086] GraphPad Prism 9 software was used for statistical analysis. The data were expressed as mean ± SEM. One-way ANOVA and Dunnett t3 test (in the case of unequal variance) were used for comparison among the groups. When P < 0.05, the difference was considered significant.

[0087] (II) Experimental results

[0088] (1) Figure 7It is the total number of scratching behaviors of mice in each group on the right cheek within 1 hour in the experiment. From the results, compared with the Control group, the scratching times of mice in the Model group (Model) increased significantly (P<0.001), indicating that the model was successfully established. Compared with the Model group, the scratching times of mice in the positive drug group (DEX) (P<0.001), the Chinese medicine compound ZYF thermosensitive sustained-release hydrogel group (ZYF+Microspheres+Hydrogels) (P<0.001), the Chinese medicine compound ZYF gel group (ZYF+Hydrogels) (without microspheres) (P<0.001), and the Chinese medicine compound ZYF group (ZYF) (P<0.01) were significantly reduced, and there was no significant difference in the blank gel group (containing microspheres) (BlankHydrogels+Microspheres).

[0089] 3. Conclusion

[0090] Compared with the model group, the Chinese medicine compound ZYF thermosensitive sustained-release hydrogel can significantly reduce the cheek scratching behavior of ACD model mice, and the therapeutic effect is close to that of the positive drug group. The number of times the mice in the Chinese medicine compound ZYF thermosensitive sustained-release hydrogel group scratched their cheeks was less than that in the Chinese medicine compound ZYF gel group and the Chinese medicine compound ZYF group. In summary, the topical Chinese medicine compound ZYF thermosensitive sustained-release hydrogel has the effect of treating non-histamine-dependent pruritus, and its effect is better than that of the Chinese medicine compound ZYF gel (without microspheres) and the Chinese medicine compound ZYF. The Chinese medicine compound ZYF thermosensitive sustained-release hydrogel has a sustained-release effect and prolongs the duration of drug action.

[0091] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.

Claims

1. A method for preparing a thermosensitive sustained-release hydrogel of a traditional Chinese medicine compound for external use, characterized in that The steps include: (1) mixing the hyaluronic acid aqueous solution and the chitosan quaternary ammonium salt aqueous solution uniformly, centrifuging to obtain the supernatant, and freeze-drying to obtain a hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried product; (2) mixing the hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried product, the Chinese medicine compound water extract freeze-dried powder, the thermosensitive material and water to obtain a Chinese medicine compound thermosensitive sustained-release hydrogel for external use; The components of the external Chinese medicine compound thermosensitive sustained-release hydrogel described in step (2) are as follows by weight percentage: hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried material 0.1-1.5%, Chinese medicine compound water extract freeze-dried powder 0.1-0.3%, thermosensitive material 18.1-26%, and water as the balance; The temperature-sensitive material is a compound of F127 and F68.

2. The method for preparing the thermosensitive sustained-release hydrogel of traditional Chinese medicine for external use according to claim 1, characterized in that: The hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried product described in step (1) has hyaluronic acid and chitosan quaternary ammonium salt in a mass ratio of 1:1; The concentration of the hyaluronic acid aqueous solution in step (1) is 0.01 to 2 mg / mL; The concentration of the chitosan quaternary ammonium salt aqueous solution described in step (1) is 0.01-2 mg / mL; The mixing method described in step (1) is to inject the chitosan quaternary ammonium salt aqueous solution into the hyaluronic acid aqueous solution under stirring, and continue stirring after the injection.

3. The method for preparing the external Chinese medicine compound thermosensitive sustained-release hydrogel according to claim 2, characterized in that: The injection rate is 0.02-0.2 mL / s; The stirring speed is 600-1200 rpm; The stirring time is 0.5 to 8 hours.

4. The method for preparing the thermosensitive sustained-release hydrogel of traditional Chinese medicine for external use according to claim 1, characterized in that: The Chinese medicine compound water extract freeze-dried powder described in step (2) is prepared by the following steps: 1) Soaking the Chinese medicinal compound in water, decocting, centrifuging the obtained medicinal solution, and taking the supernatant; 2) The supernatant obtained in step 1) is concentrated and freeze-dried to obtain freeze-dried powder of the Chinese medicine compound water extract.

5. The method for preparing the external Chinese medicine compound thermosensitive sustained-release hydrogel according to claim 4, characterized in that: The Chinese medicinal compound is composed of: sophora flavescens, cnidium monnieri, kochia scoparia, dactylum bark, galactopsis pilosula, scutellaria baicalensis and liquidambar formosana leaves in a mass ratio of 1:1:1:1:1:1:1:

1.

6. The method for preparing the thermosensitive sustained-release hydrogel of traditional Chinese medicine for external use according to claim 4, characterized in that: The amount of water used in step 1) is an amount that can immerse the Chinese medicinal compound; The soaking time in step 1) is 0.5h to 2h; The specific operation of decocting in step 1) is as follows: decocting on low heat after boiling; The centrifugation condition in step 1) is 6000-8000 rpm for 5-15 min; The concentration method in step 2) is rotary evaporation; The degree of concentration in step 2) is concentrated to 0.01 g / mL to 1.0 g of raw medicinal material / mL.

7. The method for preparing the external Chinese medicine compound thermosensitive sustained-release hydrogel according to claim 1, characterized in that: The temperature-sensitive material in step (2) is a compound of F127 and F68 in a mass ratio of 42:1; The mixing conditions in step (2) are a temperature of 2 to 8° C. and a stirring speed of 500 to 1200 rpm.

8. The method for preparing the external Chinese medicine compound thermosensitive sustained-release hydrogel according to claim 1, characterized in that: The components of the external Chinese medicine compound thermosensitive sustained-release hydrogel are calculated by mass percentage as follows: 1.0% hyaluronic acid / chitosan quaternary ammonium salt microgel freeze-dried product, 0.2% Chinese medicine compound water extract freeze-dried powder, 21.5% thermosensitive material, and the balance water.

9. A thermosensitive sustained-release hydrogel of traditional Chinese medicine for external use, characterized in that: It is prepared by the preparation method according to any one of claims 1 to 8.

10. Use of the external Chinese medicine compound thermosensitive sustained-release hydrogel according to claim 9 in the preparation of a preparation for treating non-histamine-dependent pruritus and allergic contact dermatitis.